U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
-
-
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
-
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
-
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
-
Two fatal human influenza A/H5N1 (Bird Flu) virus infections reported in Cambodia
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
New funding ensured 370 million children receive polio vaccinations in low-income countries
On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…
-
Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threats
On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…
-
FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
-
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Vaccine
Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
-
Agriculture | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
France kicked off world first bird flu vaccination despite trade backlash
On Oct. 2, 2023, France began vaccinating ducks against bird flu to try and stem the virus that…
-
Agriculture | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
USDA Protected U.S. Poultry with Restrictions on Poultry Products from France and the European Union
On Sept. 29, 2023, The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced it…
-
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
-
USDA provided more than $12 million in funding to control and prevent chronic wasting disease
On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
-
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
-
West Nile virus reported in humans and horses from four counties in Washington state
On Sept. 25, 2023, the Washington State Department of Health confirmed the presence of West Nile virus in…
-
National Institutes of Health clinical trial of universal flu vaccine candidate began
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
-
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
-
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
-
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
-
Avian influenza outbreak impacted shorebirds and seals near Fort Flagler State Park in Washington
On Sept. 1, 2023, the Washington State Department of Health announced an outbreak of avian influenza, also known…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
-
CDC’s ACIP announced vaccines recommendation for 2023-24 seasonal influenza
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
-
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
-
U.S. FDA approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
-
BD received 510(k) clearance for COVID-19, influenza A/B, RSV molecular combination test
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
-
Finnish Food Authority ordered all minks be put down at fur farms with diagnosed avian influenza infections
On Aug. 1, 2023, the Finnish Food Authority specified the euthanasia criteria for fur animals infected with avian…
-
Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 reported in United Republic of Tanzania and Kenya
On Jul. 28, 2023, the World Health Organization (WHO) reported circulating vaccine-derived poliovirus type 2 (cVDPV2) in the…
-
WHO reported influenza A(H5N1) identified in cats across Poland
On Jul. 27, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
